Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD
Clinical trial NCT05784779 · UNKNOWN
Trial details
- NCT number
- NCT05784779
- Sponsor
- 1Globe Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2024-05-28
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.